Provided by Tiger Trade Technology Pte. Ltd.

Impact Biomedical, Inc.

0.4800
+0.03076.83%
Post-market: 0.4789-0.0011-0.23%19:30 EDT
Volume:22.75K
Turnover:10.44K
Market Cap:51.84M
PE:68.57
High:0.4800
Open:0.4383
Low:0.4383
Close:0.4493
52wk High:0.8300
52wk Low:0.3700
Shares:108.00M
Float Shares:11.49M
Volume Ratio:0.60
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0070
EPS(LYR):-0.3800
ROE:23.46%
ROA:-17.79%
PB:4.82
PE(LYR):-1.26

Loading ...

Company Profile

Company Name:
Impact Biomedical, Inc.
Exchange:
AMEX
Establishment Date:
2018
Employees:
2
Office Location:
1400 Broadfield Blvd.,Suite 130,Houston,Texas,United States
Zip Code:
77084
Fax:
- -
Introduction:
Impact BioMedical Inc. is a Nevada corporation established on October 16, 2018, and a subsidiary of DSS, Inc. The company is dedicated to discovering, validating, and patenting unique scientific technologies, and collaborates with external partners through licensing, co-development, joint ventures, and other partnerships to develop new products in the field of human health.

Directors

Name
Position
Frank D. Heuszel
Chairman of the Board and Chief Executive Officer and Director
Castel Hibbert
Director
Heng Fai Ambrose Chan
Director
Christian Zimmerman
Director
David Keene
Director
Elise Brownell
Director
Jason Grady
Director
Melissa Sims
Director

Shareholders

Name
Position
Frank D. Heuszel
Chairman of the Board and Chief Executive Officer and Director
Mark Suseck
Chief Operating Officer
Todd D. Macko
Chief Financial Officer